Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multicentre, randomized, parallel, double-blind, vehicle controlled study to evaluate the efficacy and safety of Actikerall solution in the field-directed treatment of actinic keratoses grade I to II (field cancerization)

Next Previous
X
Search
Trial Profile

Multicentre, randomized, parallel, double-blind, vehicle controlled study to evaluate the efficacy and safety of Actikerall solution in the field-directed treatment of actinic keratoses grade I to II (field cancerization)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 06 Apr 2017

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fluorouracil/salicylic-acid (Primary)
  • Indications Actinic keratosis
  • Focus Registrational; Therapeutic Use
  • Sponsors Almirall Hermal GmbH; Almirall S.A.

    • Most Recent Events

    • 01 Mar 2017 Results (n=163) published in the Dermatology and Therapy
    • 05 Sep 2016 Primary endpoint has been met. (Percentage of patients with complete clinical clearance (CCC) of AK lesions in the treatment field at 8 weeks post last treatment [Timepoint: 8 weeks post last treatment ])
    • 05 Sep 2016 According to an Almirall media release, results from this study have been presented at the 16th World Congress on Cancers of the Skin & 12th Congress of the European Association of Dermato Oncology (EADO).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top